What You Should Know About The Anti-Alzheimer’s Drug Lecanemab
What should people living with dementia and their families take away from the recent data published on lecanemab, the Alzheimer’s drug developed by Biogen and the Japanese firm Eisai? The drugmakers’ announcement of their Phase 3 trial results got lots of attention in the popular press. Some stories heralded the drug as a “breakthough.” But even experts disagree about the [...]